View the 2025 Judges

The 2025 judging panel is made up of a diverse group of experts from across the industry. Whether they’ve developed their own therapy or created an innovative technology to support therapeutic advancement, our judges are uniquely qualified to review and score the award submissions. Please note that each category has five judges, and we’ve ensured that no one who could be considered a competitor will judge your category.

CEO, OX2 Therapeutics

Jeff is a seasoned CEO with a proven track record at profitably growing emerging companies and bu…

Co-Founder and Executive Managing Director, Centre for Breakthrough Medicines

Audrey Greenberg is Co-founder of the Center for Breakthrough Medicines and Discovery Labs where …

CEO, Propel Biosciences

Susan is CEO of Propel BioSciences Inc. where she leads a team who support the business development, drug development and fr…

Professor, University of Pennsylvania

Dr. Bruce Levine, Barbara and Edward Netter Professor in Cancer Gene Therapy, is the Founding Director of the Clinical Cell …

CEO & Founder, Siren Biotechnology
Director, Powell Gene Therapy Center, University of Florida

 

 

Operating Partner, Catalio Capital Management
Executive Director, Cell and Gene Therapy Center, IQVIA
Executive Chairman, KELI Therapeutics & Founding Partner, Altius Ventures
Managing Director, EuroFins
Chief Technology Officer, Gamma Biosciences
Vice Chairman, Head of M&A and Strategic Advisory Services, H.C. Wainwright & Co., LLC
Chief Clinical Officer, Cell & Gene Therapy Catapult
Education and Organizational Leadership Consultant, BioPlan Associates, Inc
Chief Technology Officer, GenEdit
Site Head of Cell & Gene Translational Services, Sr. Director R&D, Thermo Fisher Scientific